Reviewed clinical summary · Source-linked · Educational use only

How does weight-adjusted waist index predict cardiovascular outcomes in type 2 diabetes?

Clinical Bottom Line

An observational ACCORD analysis finds higher weight-adjusted waist index is independently associated with more cardiovascular events, heart failure, and mortality in type 2 diabetes, outperforming BMI. PICO summary and commentary.

Summary: In an observational analysis of the ACCORD cohort, a higher weight-adjusted waist index was independently associated with more cardiovascular events, heart failure, and total mortality in type 2 diabetes, and predicted risk better than BMI or waist circumference alone.

PICO Summary

ElementDetail
PopulationPatients with type 2 diabetes in the ACCORD trial; observational secondary analysis, USA/China.
InterventionWeight-adjusted waist index (WWI: waist circumference divided by the square root of body weight) as a prognostic marker.
ComparisonTraditional obesity indices (BMI and waist circumference).
OutcomePer 1-SD higher WWI, risk rose for major adverse cardiovascular events (HR 1.07), the composite of MI/stroke/any death (HR 1.09), congestive heart failure (HR 1.20), and total mortality (HR 1.11). Associations with heart failure and mortality were nonlinear, and WWI predicted heart failure best in those with diabetes under 10 years. Adding WWI improved conventional predictive models.

Expert Commentary

This is a sound observational prognostic analysis with a sensible rationale, since BMI cannot separate muscle from fat and waist circumference ignores body size, whereas the weight-adjusted waist index aims to capture metabolically harmful central adiposity, which is exactly the fat depot most tied to cardiovascular risk in diabetes where the obesity paradox muddies BMI interpretation. The associations are consistent and biologically coherent, strongest for heart failure, and the index has the practical virtue of needing only two routine measurements. The essential caveat is that this is associational, not interventional: it shows WWI predicts risk, not that acting on it changes outcomes. Other limits the post fairly notes include a secondary analysis of a trial not designed for this question, an older ACCORD population predating modern cardiorenal therapies, and no established risk thresholds, which blunts immediate bedside use. Can I use this with my patients? Yes, as a refinement to risk thinking rather than a new target. A high WWI despite near-normal BMI is a useful flag that a patient carries high-risk central adiposity warranting attention to exercise, diet, and therapies that reduce visceral fat, while I would not yet treat to a WWI goal in the absence of trials showing that WWI-guided intensification improves outcomes.

References

Liu M, Pei J, Zeng C, Xin Y, Tang P, Hu X. Associations and predictive value of weight-adjusted waist index for cardiovascular outcomes in type 2 diabetes: evidence from the ACCORD study. Nutr J. 2025;24(1):184. doi:10.1186/s12937-025-01251-0

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.